DERIVATIVES OF QUINOLINE, METHOD FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT WITH THEIR USING Russian patent published in 2003 - IPC

Abstract RU 2213734 C2

FIELD: organic chemistry, chemical technology, medicine, pharmacy. SUBSTANCE: invention describes derivatives of quinoline of the formula (I) wherein R means methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec.-butyl; R' means hydrogen atom, methyl, methoxy-group, fluorine, chlorine, bromine atoms, CF3 or OCHxFy; R'' means hydrogen or fluorine atom under condition that R'' means fluorine when R' means fluorine atom also and when R' and R'' are both hydrogen atoms then R is not methyl group; R4 means hydrogen atom, or pharmaceutically acceptable inorganic or organic cation; R5 means MeS, EtS, n-PrS, iso-PrS, MeSO, EtSO being x = 0-2; y = 1-3 under condition that x + y = 3; Me means methyl; Et means ethyl, Pr means propyl and Bu means butyl and any tautomers, optical isomers and racemates of these compounds also. Invention describes also pharmaceutical composition eliciting anti-auotoimmune and anti-inflammatory effect containing compounds of the general formula (I) in common with pharmaceutically acceptable carrier, to methods for preparing compounds of the formula (I) and to methods of treatment of mammals suffering with autoimmunity and pathological inflammation by administration of compound of the formula (I) to mammal. Invention provides preparing compounds of the formula (I) eliciting anti-autoimmune and anti-inflammatory effects that can be used for treatment diseases caused by autoimmunity and pathological inflammation. EFFECT: improved preparing method, valuable medicinal properties of compounds. 35 cl, 1 tbl, 4 ex

Similar patents RU2213734C2

Title Year Author Number
METHOD FOR PREPARING QUINOLINE DERIVATIVES 2003
  • Janson Karl
RU2291861C2
QUINOLINE DERIVATIVES 1999
  • B'Erk Anders
  • Jensson Stig
  • Feks Tomas
  • Khedlund Gunnar
RU2197481C2
MEDICINAL AGENTS FOR TREATMENT OF MALIGNANT TUMORS 2000
  • Khedlund Gunnar
  • Jansson Karl
  • Jensson Stig
  • B'Erk Anders
RU2240313C2
THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE 2005
  • B'Erk Anders
  • Janson Karl
RU2374250C2
DERIVATIVES OF QUINOLINE, METHOD FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT WITH THEIR USING 1999
  • B'Erk Anders
  • Jensson Stig
  • Feks Tomas
  • Khedlund Gunnar
RU2213733C2
NOVEL COMPOSITIONS CONTAINING QUINOLINE COMPOUNDS 2005
  • Janson Karl
  • Fristedt Tomas
  • Vehnnman Khans
  • B'Erk Anders
RU2339622C2
DEUTERIUM-ENRICHED 4-HYDROXY-5-METHOXY-N,1-DIMETHYL-2-OXO-N-[(4-TRIFLUORO-METHYL)PHENYL]-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE 2012
  • Svenson Lejf
RU2608306C2
PYRAZOLQUINOLINES WITH IMMUNOMODULATING ACTIVITY 2003
  • Mehtt'Juz Iehn Richard
  • Koulter Tomas Stiven
  • Giron Chiara
  • Brennan Kris Dzhejms
  • Uddin Mukhammed Kamal'
  • Pettersson Lars Olof Jeran
  • Trige Dorte Da Grasa
  • Khaksli Filip
RU2328496C2
2,5-DIOXOIMIDAZOLIN-4-YL METHYLCARBONYL COMPOUNDS, METHOD OF OBTAINING THEM, PHARMACEUTICAL MIXTURES CONTAING THEM AND THIR USE IN MEDICINE PREPARATION 2003
  • Khenriksson Krister
  • Munk Af Rozenkhol'D Magnus
RU2326117C2
COMBINATION OF TASQUINIMOD OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND PD-1 AND/OR PD-L1 INHIBITOR FOR USE AS A MEDICINAL AGENT 2016
  • Soares Khose Amauri
  • Shetaj Erik
  • Nekl Dzhessika
  • Shmidlen Faben
RU2742373C2

RU 2 213 734 C2

Authors

B'Erk Anders

Jensson Stig

Feks Tomas

Khedlund Gunnar

Dates

2003-10-10Published

1999-07-14Filed